Aspen Aerogels, Inc. (NYSE:ASPN) Given Average Recommendation of “Moderate Buy” by Analysts

Aspen Aerogels, Inc. (NYSE:ASPN) has earned a consensus recommendation of “Moderate Buy” from the ten research firms that are presently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a hold recommendation and nine have given a buy recommendation to the company. The average 12-month target price among brokers that have issued a report on the stock in the last year is $19.11.

Several research firms have recently issued reports on ASPN. StockNews.com raised Aspen Aerogels to a “sell” rating in a research note on Wednesday, February 19th. Roth Mkm decreased their price target on Aspen Aerogels from $22.00 to $16.00 and set a “buy” rating for the company in a research note on Friday, February 14th. B. Riley decreased their price target on Aspen Aerogels from $35.00 to $22.00 and set a “buy” rating for the company in a research note on Wednesday, February 19th. Barclays decreased their price target on Aspen Aerogels from $25.00 to $13.00 and set an “overweight” rating for the company in a research note on Wednesday, February 19th. Finally, Craig Hallum decreased their price target on Aspen Aerogels from $21.00 to $18.00 and set a “buy” rating for the company in a research note on Friday, February 14th.

Institutional Trading of Aspen Aerogels

Several institutional investors and hedge funds have recently added to or reduced their stakes in ASPN. Millennium Management LLC lifted its stake in Aspen Aerogels by 4,757.8% during the fourth quarter. Millennium Management LLC now owns 1,622,022 shares of the construction company’s stock valued at $19,270,000 after purchasing an additional 1,588,632 shares during the last quarter. Point72 Asset Management L.P. acquired a new stake in Aspen Aerogels during the fourth quarter valued at approximately $13,122,000. Alyeska Investment Group L.P. acquired a new stake in Aspen Aerogels during the fourth quarter valued at approximately $9,504,000. Dendur Capital LP acquired a new stake in Aspen Aerogels during the fourth quarter valued at approximately $9,207,000. Finally, FMR LLC lifted its stake in Aspen Aerogels by 23.6% during the third quarter. FMR LLC now owns 4,050,896 shares of the construction company’s stock valued at $112,169,000 after purchasing an additional 773,647 shares during the last quarter. 97.64% of the stock is owned by institutional investors and hedge funds.

Aspen Aerogels Price Performance

Shares of ASPN opened at $7.66 on Tuesday. The company has a market cap of $628.16 million, a P/E ratio of 47.85 and a beta of 2.28. The stock has a fifty day moving average price of $10.61 and a 200 day moving average price of $16.60. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.93 and a quick ratio of 2.48. Aspen Aerogels has a 12 month low of $6.70 and a 12 month high of $33.15.

Aspen Aerogels (NYSE:ASPN) last issued its quarterly earnings data on Wednesday, February 12th. The construction company reported $0.15 EPS for the quarter, topping analysts’ consensus estimates of $0.04 by $0.11. Aspen Aerogels had a return on equity of 7.49% and a net margin of 2.95%. On average, research analysts forecast that Aspen Aerogels will post 0.17 earnings per share for the current year.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.